Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region | PLOS ONE
ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results | Journal of Chemical Information and Modeling
Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer - Thrombosis Research
Biomedicines | Free Full-Text | Mycobacterium tuberculosis Affects Protein and Lipid Content of Circulating Exosomes in Infected Patients Depending on Tuberculosis Disease State | HTML
Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region | PLOS ONE
Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke | Neurology
Antibodies and tuberculosis: finally coming of age? | Nature Reviews Immunology
Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study | Scientific Reports
Biomedicines | Free Full-Text | Mycobacterium tuberculosis Affects Protein and Lipid Content of Circulating Exosomes in Infected Patients Depending on Tuberculosis Disease State | HTML
Biomedicines | Free Full-Text | Mycobacterium tuberculosis Affects Protein and Lipid Content of Circulating Exosomes in Infected Patients Depending on Tuberculosis Disease State | HTML
![PDF] Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis](https://i1.rgstatic.net/publication/326474708_Application_of_multiplexed_ion_mobility_spectrometry_towards_the_identification_of_host_protein_signatures_of_treatment_effect_in_pulmonary_tuberculosis/links/5bc14247a6fdcc2c91faf738/largepreview.png "PDF] Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis")
PDF] Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
Haemostatic Indices as Markers for Monitoring Pulmonary Tuberculosis Treatment
PDF) Mean Platelet Volume As An Inflammation Marker In Active Pulmonary Tuberculosis.
Evaluation of Peripheral Blood Parameters of Pulmonary Tuberculosis Pa | JBM
The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study
Biomedicines | Free Full-Text | Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment | HTML
IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting | Scientific Reports
The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment‐naïve, asymptomatic HIV‐infected individuals - Nkambule - 2015 - International Journal of Laboratory Hematology - Wiley Online Library
Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region | PLOS ONE
Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus - Thrombosis Research
PDF) Haemostatic Indices as Markers for Monitoring Pulmonary Tuberculosis Treatment
Patients with tuberculosis and diabetes mellitus | IDR
Hematological Abnormalities of Pulmonary Tuberculosis Patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study
Patients with tuberculosis and diabetes mellitus | IDR
Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke | Neurology
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial - The Lancet Infectious Diseases
